Albinterferon alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis c virus genotype 2 or 3
David R. Nelson, Yves Benhamou, Wanlong Chuang, Eric J. Lawitz, Maribel Rodrigueztorres, Robert Flisiak, Jens W.F. Rasenack, Wiesaw Kryczka, Chuanmo Lee, Vincent G. Bain, Stephen Pianko, Keyur Patel, Patrick W. Cronin, Erik Pulkstenis, G. Mani Subramanian, John G. McHutchison
Profundice en los temas de investigación de 'Albinterferon alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis c virus genotype 2 or 3'. En conjunto forman una huella única.